Tirzepatide Lyophilized High Purity 99% Peptide Powder 60mg kowace vial don ciwon sukari da asarar nauyi

Tirzepatide Lyophilized Foda (60 MG)

Tirzepatide (LY3298176) shine farkon agonist mai aiki biyu wanda ke hari duka GIP (glucose-dogara insulinotropic polypeptide) da GLP-1 (glucagon-like peptide-1). Ya sami amincewar FDA ta Amurka a cikin Mayu 2022 don kula da nau'in ciwon sukari na 2 (T2DM) azaman haɗin kai ga abinci da motsa jiki.
Ana ba da wannan samfurin azaman 60mg lyophilized (daskare-bushe) foda mara kyau a cikin vials, wanda dole ne a sake gina shi da ruwan bacteriostatic kafin gudanarwa. Idan aka kwatanta da guda GLP-1 agonists mai karɓa irin su semaglutide ko dulaglutide, tirzepatide yana nuna ingantaccen inganci don haɓaka tsarin glucose na jini, haɓaka haɓakar insulin, da tallafawa babban asarar nauyi. Ana danganta waɗannan fa'idodin zuwa tsarin aikin haɗin kai na mai karɓa biyu.

Mabuɗin Amfani
Gudanar da Glycemic

• Yana ƙarfafa ƙwayar insulin ta hanyar dogaro da glucose
• Yana rage fitowar glucagon, yadda ya kamata yana rage matakan glucose na jini
• Yana daidaita tasirin tasirin rayuwa na duka GIP da GLP-1

Gudanar da Nauyi

• Yana inganta satiety kuma yana rage yawan caloric
• An nuna mahimmin rashi mai dorewa a cikin nazarin asibiti

Lafiyar Zuciya

• Bayanan farko sun nuna yuwuwar rage haɗarin cututtukan zuciya a cikin marasa lafiya tare da T2DM

Amfani da Dosage

• Tirzepatide lyophilized foda (60 MG) ya kamata a sake gina shi tare da ruwan bacteriostatic kafin amfani. Gudanarwa ta hanyar allurar subcutaneous, yawanci sau ɗaya a mako a rana ɗaya kowane mako.

Nau'in ciwon sukari na 2

• Yawan farawa: 2.5 MG sau ɗaya a mako
• Titration: Ƙara kowane mako 4 kamar yadda aka jure
• (→ 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg → 20 mg → 30 mg → 45 mg → har zuwa 60 mg)
• Maganin gama gari: 10-30 MG kowane mako
• Matsakaicin Matsakaicin: 60 MG kowane mako

Kiba / Gudanar da Nauyi

• Yawan farawa: 2.5 MG sau ɗaya a mako
• Titration: Girman kashi a hankali kamar yadda aka jure
• (2.5 → 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60 mg)
• Maganin gama gari: 30-60 MG kowane mako
• Matsakaicin Matsakaicin: 60 MG kowane mako

Kwatancen Sashi na Musamman

Lura:Tabbatar cewa kowane kashi na baya yana da haƙuri sosai kafin haɓakawa.

Matsaloli masu yiwuwa

• Gastrointestinal: tashin zuciya, amai, gudawa, da rashin jin daɗi na ciki (yawanci lokacin farawa)
• Hypoglycemia: Gabaɗaya ƙarancin haɗari, amma yana ƙaruwa idan an haɗa shi da sauran magungunan rigakafin ciwon sukari
• Abubuwan da ke faruwa a wurin allura: Ja, ƙaiƙayi, kumburi, ko ɗan raɗaɗi a wurin
• Pancreatitis: Rare amma mai yiwuwa; saka idanu don ci gaba da ciwon ciki
• Effects Renal: Ana iya buƙatar saka idanu akan aikin koda a wasu mutane

Pharmacokinetics

• Rabin Rayuwa: Kimanin mako 1
• Yawan Adawa: Yana goyan bayan gudanarwa mai dacewa sau ɗaya-mako

Takaitawa
Tirzepatide 60 MG lyophilized foda yana wakiltar ci gaban warkewa na gaba-gaba, yana haɗa ikon sarrafa glycemic mai ƙarfi tare da ingantaccen asarar nauyi da yuwuwar kariyar zuciya.
Tare da jadawalin titration a hankali (2.5 MG → har zuwa 60 MG), yana ba da damar haɓaka juriya da sassauci don jiyya ɗaya. Gudanarwar sa na mako-mako sau ɗaya yana inganta riko, yana mai da shi sabon zaɓi mai inganci don gudanar da nau'in ciwon sukari na 2 da kiba a cikin ci gaba na asibiti da saitunan bincike.